ETF PROAI

IHEvsXLV

iShares U.S. Pharmaceuticals ETF against Health Care Select Sector SPDR Fund — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IHE 132XLV 116Oct 25Oct 26GROWTH OF $100
Head to head
IHEXLV
Expense ratio0.40%0.090%
Assets$1.6B$43.4B
Net flow, 1 month+$39M−$347M
Net flow, 1 year+$818M+$1.6B
Return, YTD+16.3%+7.4%
Return, 1 year+32.3%+16.1%
Avg daily volume159K8M
Holdings3864
ListedMay 1, 2006Dec 16, 1998
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.